ECSP13012650A - Métodos y composiciones para tratar diarrea asociada con vih - Google Patents

Métodos y composiciones para tratar diarrea asociada con vih

Info

Publication number
ECSP13012650A
ECSP13012650A ECSP13012650A ECSP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A
Authority
EC
Ecuador
Prior art keywords
diarrhea
methods
hiv
compositions
diarrhea associated
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Salix Pharmaceuticals Ltd
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012650(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salix Pharmaceuticals Ltd, Napo Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Ltd
Publication of ECSP13012650A publication Critical patent/ECSP13012650A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
ECSP13012650 2010-10-31 2013-05-31 Métodos y composiciones para tratar diarrea asociada con vih ECSP13012650A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
ECSP13012650A true ECSP13012650A (es) 2013-10-31

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012650 ECSP13012650A (es) 2010-10-31 2013-05-31 Métodos y composiciones para tratar diarrea asociada con vih

Country Status (20)

Country Link
US (4) US8962680B2 (https=)
EP (1) EP2632550B1 (https=)
JP (2) JP6063385B2 (https=)
CN (2) CN107595836A (https=)
AU (1) AU2011320155B2 (https=)
BR (1) BR112013010774A2 (https=)
CA (1) CA2816416C (https=)
DK (1) DK2632550T3 (https=)
EC (1) ECSP13012650A (https=)
ES (1) ES2635435T3 (https=)
HK (1) HK1249036A1 (https=)
HU (1) HUE035393T2 (https=)
MX (1) MX348184B (https=)
PE (1) PE20140036A1 (https=)
PH (1) PH12013500857A1 (https=)
PL (1) PL2632550T3 (https=)
PT (1) PT2632550T (https=)
RU (1) RU2597746C2 (https=)
WO (1) WO2012058664A1 (https=)
ZA (1) ZA201303136B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
EP2928560A4 (en) * 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JP7328153B2 (ja) 2017-05-31 2023-08-16 ナポ ファーマシューティカルズ インク． 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物
US11857510B2 (en) 2017-05-31 2024-01-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating congenital diarrhea disorder
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CA3182864A1 (en) * 2020-06-19 2021-12-23 Lisa A. CONTE Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP2060183A3 (en) 1996-10-16 2009-06-03 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2008546790A (ja) * 2005-06-22 2008-12-25 ユニバーシティー オブ マサチューセッツ Ｈｉｖ−１プロテアーゼ阻害剤
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
SI2241318T1 (sl) * 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
AU2010303577B2 (en) 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
BR112014015314A2 (pt) 2011-12-22 2017-06-13 Glenmark Pharmaceuticals Ltd composição farmacêutica não entérica compreendendo crofelemer
EP2928560A4 (en) 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA

Also Published As

Publication number Publication date
US8962680B2 (en) 2015-02-24
EP2632550B1 (en) 2017-05-03
CN103370101A (zh) 2013-10-23
PE20140036A1 (es) 2014-01-31
RU2013123794A (ru) 2014-12-10
WO2012058664A1 (en) 2012-05-03
MX2013004873A (es) 2013-08-21
US20120107370A1 (en) 2012-05-03
MX348184B (es) 2017-06-02
HUE035393T2 (en) 2018-05-02
ES2635435T3 (es) 2017-10-03
DK2632550T3 (en) 2017-08-07
AU2011320155B2 (en) 2016-02-25
CA2816416A1 (en) 2012-05-03
CA2816416C (en) 2020-02-11
US20140294903A1 (en) 2014-10-02
US9585868B2 (en) 2017-03-07
EP2632550A4 (en) 2014-04-23
US20120184605A1 (en) 2012-07-19
EP2632550A1 (en) 2013-09-04
PH12013500857A1 (en) 2018-01-17
PL2632550T3 (pl) 2017-10-31
JP2017019806A (ja) 2017-01-26
JP6310971B2 (ja) 2018-04-11
JP2013540826A (ja) 2013-11-07
ZA201303136B (en) 2016-01-27
AU2011320155A1 (en) 2013-05-09
HK1249036A1 (zh) 2018-10-26
JP6063385B2 (ja) 2017-01-18
US20150190367A1 (en) 2015-07-09
RU2597746C2 (ru) 2016-09-20
CN107595836A (zh) 2018-01-19
PT2632550T (pt) 2017-08-02
BR112013010774A2 (pt) 2017-03-21

Similar Documents

Publication Publication Date Title
ECSP13012650A (es) Métodos y composiciones para tratar diarrea asociada con vih
MX382400B (es) Metodo para el tratamiento de sindrome del intestino irritable predominante-diarrea.
ECSP15030799A (es) Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y métodos de tratamiento con los mismos
NZ602219A (en) Methods and compositions for treating degos’ disease
ECSP12012106A (es) Terapia antiviral
CR20140410A (es) Esketamina para el tratamiento de la depresión refractaria al tratamiento o resistente al tratamiento
EA201201186A1 (ru) ИСПОЛЬЗОВАНИЕ ErbB3 ИНГИБИТОРОВ В ЛЕЧЕНИИ ТРИЖДЫ НЕГАТИВНОГО И БАЗАЛЬНО-ПОДОБНОГО ВИДОВ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
CR11724A (es) Agente para tratar enfermedades
NI201400112A (es) Tratamiento del cáncer con inhibidores tor cinasa
MX2020004516A (es) Metodos y composiciones para la dosificacion de celulas t con receptor de antigeno quimerico alogenicas.
BR112014019350A8 (pt) Composição terapêutica estéril, seu uso para tratar diarreia induzida por rotavírus e embalagem
ECSP13012551A (es) Terapia de combinación para tratar infección por hcv.
DOP2013000131A (es) Composiciones y métodos para tratar el cáncer usando un inhibidor de pi3k y un inhibidor de mek
MX2015007065A (es) Metodo y composiciones para tratar diarrea asociada con vih.
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
CO6731081A2 (es) Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol
CO6670518A2 (es) Tratamiento de infecciones de clostridium difícile en pacientes bajo terapia con antibióticos
MX2014003873A (es) Metodo para tratar el carcinoma mucoepidermoide.
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
CO6771411A2 (es) Metodos y composiciones para tratar diarrea asociada al vih
MX2022016367A (es) Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.
GT201400071A (es) Combinación terapéutica para el tratamiento de cáncer
EA201491836A1 (ru) Способы лечения рака с использованием ингибитора pi3k и ингибитора mek
AR092169A1 (es) Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararla
CL2022003634A1 (es) Métodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.